Navigation Links
Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update
Date:5/3/2011

HAYWARD, Calif., May 3, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended March 31, 2011.

Financial Results:

Total operating expenses for the first quarter ended March 31, 2011 were $18.7 million, as compared to $6.5 million for the same period in 2010. The increased operating expenses in the first quarter of 2011 were driven by expenses related to site initiations and the active enrollment of patients in our Phase 3 VISTA-16 study (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks), which is an event driven study in Acute Coronary Syndrome (ACS) patients studying the benefit of varespladib anti-inflammatory treatment in high risk patients. In addition, the increased manufacturing expenses related to the development of A-623, our large molecule inhibitor of BAFF, and the accelerating enrollment of Anthera's Phase 2b study, PEARL-SC (A Randomized, Double-Blind Phase 2b Study to Evaluate the Efficacy, Safety, and Tolerability of A623 AdministRation in Subjects with Systemic Lupus Erythematosus) at up to 90 clinical sites in up to 12 countries contributed to the increased expense. The quarterly results also reflect the previously anticipated increase in professional services and other costs associated with operating as a public company.

Anthera ended the first quarter of 2011 with approximately $78.5 million in cash and cash equivalents and short-term investments, which includes approximately $25.0 million of gross proceeds received from a term loan which closed on March 25, 2011. This is compared to $63.4 million in cash and cash equivalents and short-term investments for the fourth quarter ended December 31, 2010.

Recent Business Highlights and Upcoming Events:
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
2. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
3. Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
4. Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
5. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
6. Anthera Announces Update Call Regarding Vial Problems
7. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
8. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
9. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
10. Anthera Pharmaceuticals to Present at Deutsche Bank Securities 35th Annual Health Care Conference
11. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015  Dr. Cal Robinson , Psy.D., ... Center today, providing patients with new methods ... through psychological counseling and treatment programs. ... medical psychologist with an extensive career in pain ... from assessment and treatment of behavioral medicine disorders ...
(Date:8/3/2015)... ANGELES, Aug. 3, 2015  CytRx Corporation (NASDAQ: ... in oncology, today reported financial results for the three ... overview of recent accomplishments and upcoming milestones for its ... 2015 has been very productive for CytRx. Enrollment in ... aldoxorubicin in soft tissue sarcoma (STS) continues on track ...
(Date:8/3/2015)... FREDERICK, Md. , Aug. 3, 2015  BioElectronics ... products for pain management, announced that Andrew J. ... Taylor on his program "On Business" at 9am ... to the interview live, tune to: ... to report on the exceptional acceptance the company,s flagship ...
Breaking Medicine Technology:Orthopaedic & Spine Center Introduces New Pain Psychologist 2CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2
... 30 Wound Care,Innovations, LLC, a subsidiary of ... today that it will attend and exhibit at,the ... Boston. This,seminar is presented by HMP Communications, the ... and producers of the Symposium on,Advanced Wound Care. ...
... NIH; Findings could benefit,pregnant women worldwide, SEATTLE, ... and Human Development division of the National Institutes ... a $2.9 million grant,for a five-year research project ... known as preeclampsia and migraine., Dr. Williams ...
Cached Medicine Technology:Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R) 2Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 2Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 3
(Date:8/3/2015)... ... August 03, 2015 , ... They know every second ... St. Vincent Medical Center offers some of the best care in the nation. For ... neurointerventionalist, achieved the fastest average blood clot removal time in the country. During the ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... to contract research organisations (CROs) for a slew of benefits, allowing them to ... and operations, boost quality with cost-effective utilisation of resources, get access to innovation ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... services to help patients in need. Most people know that general health emergencies, such ... Unfortunately, a fewer amount of people know where to turn to during a dental ...
(Date:8/3/2015)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions ... Wednesday, August 12, 2015 at 9:45am (ET) at Le Parker Meridien in New York, ... be accessed via the investor relations section of the Company’s website. , About AxoGen, ...
(Date:8/3/2015)... , ... August 03, 2015 , ... A July 13 ... of Stem Cells Found to Release Natural Painkiller That Can Last 'For Five Weeks'" ... According to the report, the new study showed that harvesting stem cell-rich bone marrow ...
Breaking Medicine News(10 mins):Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3
... Ekahau Positioning Engine and Tags With ... Room Personnel, SARATOGA, California, July 30 Ekahau ... (RTLS), today announced,that the 12 de Octubre Hospital in ... is designed to improve security,and safety of its emergency ...
... 29 Microtest Laboratories has,launched a suite of ... U.S. that have yet failed to meet mandatory ... also announced,its offer of a free facility-gap-analysis audit ... level and corresponding,preparation., Pharmacies failing to comply ...
... Company,(NYSE: KVa/KVb), today reported that it is set ... -- principally cough/cold products -- previously,sold by ETHEX ... previously disclosed discussions with the FDA regarding the,agency,s ... by,ETHEX as well as other pharmaceutical companies for ...
... Challenge, SACRAMENTO, Calif., July 29 As ... Next 10 has just released,a newly updated version ... try their hand at dealing with the tradeoffs ... 2008 Budget Challenge, an online,interactive educational game, contains ...
... Pro Forma EPS Guidance, BETHESDA, Md., July 29 ... of $181.2 million for the,quarter ended June 30, 2008 an ... quarter. Net income increased by $2.9 million, or,57.2%, to $8.0 ... same,quarter last year., Pro forma net income applicable to ...
... LITTLE ROCK, Ark., July 29 Heifer International ... corporate partnership,agreement. Heifer International is a world hunger ... Greenfield, Indiana, that has,offices in 30 countries around ... improve animal health and productivity., The partnership ...
Cached Medicine News:Health News:Madrid Hospital Improves Employee Safety With Ekahau Wi-Fi RTLS 2Health News:Madrid Hospital Improves Employee Safety With Ekahau Wi-Fi RTLS 3Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 3Health News:KV Set to Dispose of Previously Written Off Guaifenesin Inventory 2Health News:KV Set to Dispose of Previously Written Off Guaifenesin Inventory 3Health News:As Budget Stalemate Wears On - Voters Can Set Their Own Priorities 2Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 2Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 3Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 4Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 5Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 6Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 7Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 8Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 9Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 10Health News:Heifer and Elanco Announce Charitable Partnership 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
... Signature is a state of the ... integrates blood, sterile body fluid and ... microbiology workstation with comprehensive capabilities. It ... and where expanded flexibility in operating ...
... The BacT/Alert 3D Select ... art, automated microbial detection system ... fluid and mycobacteria culturing. This ... data management or laboratory information ...
Medicine Products: